Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS-4059) Given as Monotherapy in Participants With Relapsed/Refractory NHL and CLL
Clinical trial NCT01659255 · COMPLETED
Trial details
- NCT number
- NCT01659255
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-17
- Primary completion
- 2015-02-23
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.